- Home
- NARI vs ALVO Comparison
NARI vs ALVO Comparison
Compare NARI & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NARI
- ALVO
- Stock Information
- Founded
- NARI 2011
- ALVO 2013
- Country
- NARI United States
- ALVO Luxembourg
- Employees
- NARI N/A
- ALVO N/A
- Industry
- NARI Medical/Dental Instruments
- ALVO Biotechnology: Pharmaceutical Preparations
- Sector
- NARI Health Care
- ALVO Health Care
- Exchange
- NARI Nasdaq
- ALVO Nasdaq
- Market Cap
- NARI 4.7B
- ALVO 4.0B
- IPO Year
- NARI 2020
- ALVO N/A
- Fundamental
- Price
- NARI $79.87
- ALVO $12.59
- Analyst Decision
- NARI Hold
- ALVO Buy
- Analyst Count
- NARI 12
- ALVO 1
- Target Price
- NARI $69.22
- ALVO $18.00
- AVG Volume (30 Days)
- NARI 4.8M
- ALVO 193.2K
- Earning Date
- NARI 02-26-2025
- ALVO 03-19-2025
- Dividend Yield
- NARI N/A
- ALVO N/A
- EPS Growth
- NARI N/A
- ALVO N/A
- EPS
- NARI N/A
- ALVO N/A
- Revenue
- NARI $574,498,000.00
- ALVO $393,919,000.00
- Revenue This Year
- NARI $24.62
- ALVO $398.12
- Revenue Next Year
- NARI $18.00
- ALVO $44.73
- P/E Ratio
- NARI N/A
- ALVO N/A
- Revenue Growth
- NARI 22.41
- ALVO 517.92
- 52 Week Low
- NARI $36.73
- ALVO $9.15
- 52 Week High
- NARI $79.89
- ALVO $18.00
- Technical
- Relative Strength Index (RSI)
- NARI 80.06
- ALVO 45.69
- Support Level
- NARI $79.60
- ALVO $12.05
- Resistance Level
- NARI $79.76
- ALVO $12.75
- Average True Range (ATR)
- NARI 0.18
- ALVO 0.34
- MACD
- NARI -0.79
- ALVO -0.11
- Stochastic Oscillator
- NARI 93.33
- ALVO 37.28
About NARI Inari Medical Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
About ALVO Alvotech
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.